Search results
Found 12698 matches for
Researchers at the University of Oxford led by DPAG's Professor Peter Robbins are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is important in COVID-19, because many patients with the disease die when oxygen levels in their arterial blood fall to levels that are too low to support life.
Molnár, Mann, Bannerman and Lak Groups publish collaborative research on anxiety
28 April 2025
New Research Uncovers Key Brain Cells Behind Anxiety and Stress Responses
Remembering the Need for Sleep
1 April 2025
Sleep is the only ubiquitous behaviour whose function remains unknown. The Miesenböck group is looking for—and finding—clues to the mystery of sleep in the properties of sleep-inducing cells in the brain.